The objective of the procurement is to establish framework agreements for the delivery of heart valves for catheter based implantation and equipment for Helse Nord RHF, Helse Midt-Norway RHF, Helse Sør-Øst RHF and Helse Vest RHF. The value of the entire procurement is estimated to be around NOK 244,000,000 per annum. The maximum value in the contract period is set to NOK 1,074,600,000 for the product area. The stated consumption/extent is an estimate for information to the tenderer and is not binding for the future contract volume. The contracting authority would like tenders for heart valves, catheter based implants (TAVI) for both children and adults at the following: health companies: - Oslo University Hospital HF- University Hospital North-Norway HF - St. Olavs Hospital HF- Haukeland University Hospital HFFor a more detailed description see the annex – "Requirement Specification" and annex – "Price form". Approx. 1,500 implantations will be carried out per annum. The number of procedures is increasing. The consumption for national contracts in 2025 was distributed as follows: SalesProductCount of pcsEvolut R1EDWARDS SAPIEN 3 ULTRA RESILIA9EvolutFX46EvolutFXpluss480Melody TPV7Navitor Vision92SAPIEN 3 Certitude2SAPIEN 3 Commander228SAPIEN 3 ULTRA Certitude2SAPIEN 3 Ultra Commander580SUM1447